478 related articles for article (PubMed ID: 22632761)
1. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
Sachlos E; Risueño RM; Laronde S; Shapovalova Z; Lee JH; Russell J; Malig M; McNicol JD; Fiebig-Comyn A; Graham M; Levadoux-Martin M; Lee JB; Giacomelli AO; Hassell JA; Fischer-Russell D; Trus MR; Foley R; Leber B; Xenocostas A; Brown ED; Collins TJ; Bhatia M
Cell; 2012 Jun; 149(6):1284-97. PubMed ID: 22632761
[TBL] [Abstract][Full Text] [Related]
2. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
Zhang Q; Lu Y; Ding Y; Zhai J; Ji Q; Ma W; Yang M; Fan H; Long J; Tong Z; Shi Y; Jia Y; Han B; Zhang W; Qiu C; Ma X; Li Q; Shi Q; Zhang H; Li D; Zhang J; Lin J; Li LY; Gao Y; Chen Y
J Med Chem; 2012 Oct; 55(20):8757-69. PubMed ID: 22985027
[TBL] [Abstract][Full Text] [Related]
3. Current status and issues in cancer stem cell study.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells as the relevant biomass for drug discovery.
Winquist RJ; Furey BF; Boucher DM
Curr Opin Pharmacol; 2010 Aug; 10(4):385-90. PubMed ID: 20630801
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell targeted agents: therapeutic approaches and consequences.
Chumsri S; Burger AM
Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells.
Roney MSI; Park SK
Arch Pharm Res; 2018 Apr; 41(4):384-408. PubMed ID: 29556831
[TBL] [Abstract][Full Text] [Related]
8. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
9. [The concept and significance of cancer stem cells].
Haraguchi N; ishii H; Sakai D; Satoh T; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):204-9. PubMed ID: 22582581
[TBL] [Abstract][Full Text] [Related]
10. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening finds potential killer of cancer stem cells.
Rowan K
J Natl Cancer Inst; 2009 Nov; 101(21):1438-9. PubMed ID: 19828869
[No Abstract] [Full Text] [Related]
12. New models for cancer research: human cancer stem cell xenografts.
Baiocchi M; Biffoni M; Ricci-Vitiani L; Pilozzi E; De Maria R
Curr Opin Pharmacol; 2010 Aug; 10(4):380-4. PubMed ID: 20561817
[TBL] [Abstract][Full Text] [Related]
13. High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.
Danovi D; Folarin AA; Baranowski B; Pollard SM
Methods Enzymol; 2012; 506():311-29. PubMed ID: 22341231
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Disease: cancer stem cells--targeting the evil twin.
Trumpp A; Wiestler OD
Nat Clin Pract Oncol; 2008 Jun; 5(6):337-47. PubMed ID: 18431377
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia stem cells.
Dick JE
Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells as a target population for drug discovery.
Bouvard C; Barefield C; Zhu S
Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells: lessons from leukemia.
Wang JC; Dick JE
Trends Cell Biol; 2005 Sep; 15(9):494-501. PubMed ID: 16084092
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor stem cells as research and treatment targets.
Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
[TBL] [Abstract][Full Text] [Related]
19. Clinical implication of targeting of cancer stem cells.
Zhao L; Zhao Y; Bao Q; Niess H; Jauch KW; Bruns CJ
Eur Surg Res; 2012; 49(1):8-15. PubMed ID: 22797579
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells.
Lee SI; Roney MSI; Park JH; Baek JY; Park J; Kim SK; Park SK
Prostate; 2019 May; 79(7):720-731. PubMed ID: 30816566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
